Edgewise Therapeutics, Inc. (EWTX) — SC 13G/A Filings
All SC 13G/A filings from Edgewise Therapeutics, Inc.. Browse 10 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (10)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Jul 10, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
FMR LLC & Abigail Johnson Maintain 10.23% Stake in Edgewise Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have filed an amended SC 13G/A, revealing they beneficially own 6,492,513 shares of Edgewise -
BlackRock Amends Edgewise Therapeutics Stake (SC 13G/A)
— Feb 7, 2024
BlackRock Inc. filed an amended SC 13G/A on February 7, 2024, indicating a change in its ownership of Edgewise Therapeutics, Inc. common stock as of January 31, -
Deerfield Mgmt Reports 545,455 Shared Shares in Edgewise Therapeutics
— Feb 1, 2024
Deerfield Mgmt, L.P. and its affiliated entities, including Deerfield Management Company, L.P., have filed an amended SC 13G/A for Edgewise Therapeutics, Inc. (
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX